Skip to main content
Crescita Therapeutics Inc. logo

Crescita Therapeutics Inc. — Investor Relations & Filings

Ticker · CTX TSX Manufacturing
Open in API
Filings indexed 165 across all filing types
Latest filing 2026-04-23 M&A Activity
Country CA Canada
Listing TSX CTX

About Crescita Therapeutics Inc.

https://www.crescitatherapeutics.com/

Crescita Therapeutics Inc. is a commercial dermatology company focused on the development, manufacturing, and commercialization of topical therapeutic products. The company leverages in-house research and development (R&D) and manufacturing capabilities to maintain an innovation-driven portfolio. This portfolio encompasses both prescription drug products and non-prescription skincare products (including over-the-counter and in-clinic formulations). Crescita's offerings are primarily utilized for the treatment and care of skin conditions, diseases, and their associated symptoms, with additional development efforts directed toward topical pain management solutions. The company distributes its products across North American and international markets.

Recent filings

Filing Released Lang Actions
Other.pdf
M&A Activity Classification · 1% confidence The document is a Letter of Transmittal used by registered shareholders to deposit their common shares under a Plan of Arrangement in which a purchaser is acquiring all issued and outstanding shares for cash. It is directly tied to an M&A transaction (arrangement/takeover), providing instructions and forms for shareholders to surrender their certificates. Therefore, it falls under M&A Activity (TAR).
2026-04-23 English
Other.pdf
Regulatory Filings Classification · 1% confidence The document is a formal certificate filed under Canadian securities rules (NI 54-101) certifying the timing of proxy materials sent to beneficial owners ahead of a special shareholder meeting. It is addressed to securities regulators and confirms compliance with proxy delivery requirements, rather than being the proxy statement itself or a general shareholder presentation. Therefore, it falls under general regulatory filings rather than a specific report or proxy statement category.
2026-04-23 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a “Notice of Meeting and Management Information Circular” sent to shareholders to solicit their votes at a Special Meeting regarding a plan of arrangement (acquisition). It includes proxy instructions, voting procedures, and management recommendations—all hallmarks of a proxy solicitation/information statement. Therefore, it matches the Proxy Solicitation & Information Statement category (PSI).
2026-04-23 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for a Special Meeting of Shareholders, used to solicit votes and provide voting instructions to shareholders. This is part of proxy solicitation materials, not a financial report or regulatory notice of results. It clearly fits the Proxy Solicitation & Information Statement category (PSI).
2026-04-23 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of Special Meeting of Shareholders that solicits proxies, provides voting instructions, record dates, and refers to an accompanying management information circular (“the Circular”) – classic proxy solicitation material. This aligns with the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-23 English
Other.pdf
M&A Activity Classification · 1% confidence The document is a Letter of Transmittal for registered holders of common shares in the context of a Plan of Arrangement (a takeover/acquisition) under which shareholders must deposit their share certificates to receive cash consideration. It provides instructions and form for completing the share exchange in connection with the Arrangement involving Crescita, ClinActiv, and the Purchaser. This clearly falls under M&A activity (takeover bid/arrangement) rather than a financial report, proxy statement, or other category.
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.